Fig. 2From: Biotin-thiamine responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of cases in Kuwait with novel variantsa–o Radiological Findings of six individuals diagnosed with Biotin Thiamine Responsive Basal Ganglia Disease in Kuwait (Cases 4, 7, 9, 15, 19, 20): a Case 4. Plain brain computed tomography (CT) showing bilateral swelling and diffuse hypodensity of putamen. b Case 4. Follow up T2-weighted brain magnetic resonance imaging (MRI) revealing bilateral caudate, putamen and external capsule atrophy sparing globus pallidus and sub-insular regions, with multiple T2 hyperintense cystic foci of necrosis/injury. c Case 7. T1 post contrast brain MRI showing bilateral T1 faint enhancement in the caudates, peripheral putamen, thalami, and some occipital leptomeningeal regions. d Case 7. T2-FLAIR image revealing bright hyperintense lesions again in the basal ganglia and thalami with diffuse bilateral subcortical involvement. e Case 7. T1-weighted post contrast image showing faint subtle enhancement of the T2-FLAIR hyperintense lesion in the vermis; (f). g, h Case 9. T2-FLAIR brain MRI showing cortical and subcortical hyperintensities at both cerebral hemispheres and subtle cerebellar changes, as well as caudate and putamen bilaterally. i Case 9. T1-weighted brain MRI image correlated with T2-weighted image j showing the basal ganglia lesions as T1 hypointense and T2 hyperintense, k Case 15. Axial and l coronal T2 weighted MR images of the brain showing bilateral symmetric hyperintense signals in the midbrain/cerebral peduncles, as well as the basal ganglia and medial thalami There are multiple cortical/subcortical and bilateral sub-insular T2 hyperintensities. m Case 19. T2-FLAIR brain MRI showing multiple scattered hyperintense lesions at the cortical and subcortical cerebral parenchyma, as well as bilateral caudate, putamen and medial thalamic nuclei. n Some of these areas showed partial diffusion restriction on DWI. o Case 20. T2-weighted brain MRI showing hyperintensity of both putamina, representing atrophy with central necrosis/injuryBack to article page